Brief: Reviva Announces Closing Of $3 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
29/05/2024 22:11
Reviva Pharmaceuticals Holdings, Inc. RVPH.O :
* REVIVA ANNOUNCES CLOSING OF $3 MILLION REGISTERED DIRECT
OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULES
Source text for Eikon: ID:nGNX3jtffC
Further company coverage: RVPH.O
Recent news on Reviva Pharmaceuticals Holdings
See all newsReviva Pharmaceuticals Q1 net loss narrows on lower expenses
Brief: Reviva Pharmaceuticals Holdings Inc - To Be Delisted From Nasdaq Trading Suspended As Of May 14, 2026 - SEC Filing
Brief: Reviva Reports Full Year 2025 Financial Results And Recent Business Highlights
Reviva Pharmaceuticals' 2025 net loss narrows on lower R&D spending
U.S. STOCKS ON THE MOVE-Darden Restaurants, Mastercard, Accenture